Publications of the Week Nanoparticle-Mediated Delivery of Anti-PU.1 siRNA via Localized Intracisternal Administration Reduces Neuroinflammation Ralvenius, W., et al. | December 15, 2023 Neuroinflammation is a hallmark of neurodegenerative disorders including Alzheimer's disease (AD). Microglia, the brain's immune…karnottDecember 15, 2023 Read More
Local News Bluebird Bio Receives US FDA Nod for Sickle Cell Therapy BioProcess International | December 15, 2023 The US Food and Drug Administration (FDA) has approved bluebird’s Lyfgenia (lovotibeglogene autotemcel) for the…karnottDecember 15, 2023 Read More
Local News Demystifying a Mammal’s Brain, Cell by Cell The Harvard Gazette | December 14, 2023 A group of scientists, including several at Harvard, have dived deeper into the mammalian brain…karnottDecember 14, 2023 Read More
Publications of the Week Lymph Node Stromal Cell Responses to Perinatal T Cell Waves, a Temporal Atlas Jayewickreme, T., et al. | December 14, 2023 Early life poses the challenge of establishing an immune system tolerant to self while still…karnottDecember 14, 2023 Read More
Local News Building Models of the Brain to Take Them Apart Harvard Medical School | December 13, 2023 Kanaka Rajan describes herself as an ever-curious, “stick-my-finger-in-the-electrical-socket kind of person” who enjoys working with…karnottDecember 13, 2023 Read More
Awards Dana-Farber’s Dr. Kornelia Polyak Recognized with the 2023 AACR Distinguished Lectureship in Breast Cancer Research Dana-Farber Cancer Institute | December 13, 2023 Dana-Farber’s Kornelia Polyak, MD, PhD, FAACR, is the recipient of the 2023 AACR Distinguished Lectureship…karnottDecember 13, 2023 Read More
Local News Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform GlobeNewswire | December 13, 2023 Tome Biosciences, Inc., the programmable genomic integration company, has launched to usher in a new…karnottDecember 13, 2023 Read More
Local News How a Mutation in Microglia Elevates Alzheimer’s Risk MIT News | December 12, 2023 A rare but potent genetic mutation that alters a protein in the brain’s immune cells,…karnottDecember 12, 2023 Read More
Local News The Lucky Break Behind the First CRISPR Treatment MIT Technology Review | December 12, 2023 The world’s first commercial gene-editing treatment is set to start changing the lives of people…karnottDecember 12, 2023 Read More
Awards K. Lisa Yang Postbaccalaureate Program Names New Scholars McGovern Institute | December 12, 2023 Two young researchers in McGovern Institute labs, Joseph Itiat and Sam Merrow, are the newest…karnottDecember 12, 2023 Read More